DCM
INFI

Driehaus Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Driehaus Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-253,338
Closed -$4.28M – 566
2014
Q4 		$4.28M Buy
+253,338
New +$3.69M 0.17% 166

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Driehaus Capital Management's INFI Position: Q1 2015 in Review

Driehaus Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 253,338 shares — an estimated $4.28M sold.

Driehaus Capital Management first reported a position in INFI in Q4 2014 and held it in 1 quarter. The position peaked at $4.28M in Q4 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Driehaus Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 253,338 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $4.28M.
  • Driehaus Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $4.28M in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Driehaus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.